Sysmex Inostics Is A Biotechnology Company Based In Baltimore And A Subsidiary Of Japanae S Sysmex Corporationthe Company Specializes In Liquid Biopsy Technologiesfocusing On Ultra Sensitive Molecular Diagnostics To Detect Cancer Related Biomarkers From Blood Samplesthis Approach Allows For Non Invasive Monitoring And Personalized Treatment Strategies The Company Offers Several Advanced Productsincluding The Oncobeama C Platformwhich Is A Digital Pcr Based Liquid Biopsy Tool For Detecting Rare Mutations In Cell Free Tumor Dnathey Also Provide Plasma Safe Seqs Ngs Panelswhich Are Next Generation Sequencing Assays That Cover Various Cancer Biomarkersadditionallysysmex Inostics Offers Clia Validated Testing Services To Pharmaceutical Companiesresearchersand Clinicians For Therapy Response Monitoring And Clinical Trial Support By Leveraging Patented Blood Based Ctdna Analysissysmex Inostics Reduces The Need For Invasive Tissue Biopsies And Enables Longitudinal Monitoring Of Minimal Residual Disease And Resistance Mechanisms In Cancerthe Company Serves Pharmaceutical Firmsclinical Researchersand Healthcare Providerssupporting Drug Discoveryprecision Oncology Trialsand Treatment Decisions Through Real Time Molecular Profiling
